Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (329)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
28
2024
176
12.870
 Why?
Anticonvulsants
16
2025
125
7.150
 Why?
Seizures
22
2024
195
5.600
 Why?
Tuberous Sclerosis
7
2024
36
4.280
 Why?
Spasms, Infantile
10
2024
28
4.160
 Why?
Cannabidiol
7
2024
35
3.980
 Why?
Status Epilepticus
6
2021
36
3.450
 Why?
Epilepsies, Myoclonic
5
2024
12
3.210
 Why?
Mutation
16
2023
1292
3.160
 Why?
Deep Brain Stimulation
4
2025
43
2.930
 Why?
Humans
112
2025
50389
2.640
 Why?
Electroencephalography
18
2024
304
2.600
 Why?
Intellectual Disability
5
2023
128
2.250
 Why?
Brain
10
2024
1313
2.210
 Why?
Child
39
2025
6877
2.150
 Why?
Hemiplegia
3
2021
10
2.080
 Why?
Developmental Disabilities
5
2019
119
1.740
 Why?
Epilepsy, Absence
3
2019
11
1.690
 Why?
Magnetic Resonance Imaging
15
2019
1534
1.620
 Why?
Algorithms
2
2025
618
1.470
 Why?
Tumor Suppressor Proteins
3
2023
127
1.450
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.440
 Why?
Nervous System Malformations
3
2020
18
1.430
 Why?
Infant
21
2024
3601
1.430
 Why?
Folate Receptor 1
2
2022
25
1.410
 Why?
Epilepsies, Partial
2
2022
12
1.320
 Why?
Infant, Newborn, Diseases
2
2020
57
1.320
 Why?
Ketamine
2
2020
59
1.310
 Why?
Neurocutaneous Syndromes
2
2019
6
1.190
 Why?
Child, Preschool
19
2024
3908
1.170
 Why?
Cadherins
2
2019
64
1.160
 Why?
Cerebral Arteries
2
2019
37
1.090
 Why?
Epilepsy, Generalized
2
2023
8
1.070
 Why?
Vigabatrin
3
2024
3
1.060
 Why?
Sirolimus
2
2017
62
1.050
 Why?
Angiofibroma
2
2015
5
1.020
 Why?
Facial Neoplasms
2
2015
22
1.000
 Why?
Nerve Tissue Proteins
2
2018
192
0.990
 Why?
Valproic Acid
2
2022
32
0.980
 Why?
Vagus Nerve Stimulation
1
2025
12
0.960
 Why?
Stroke
3
2019
485
0.940
 Why?
Fenfluramine
2
2024
8
0.930
 Why?
Randomized Controlled Trials as Topic
2
2024
556
0.930
 Why?
Dioxolanes
2
2024
13
0.920
 Why?
Thalamus
1
2024
36
0.920
 Why?
Male
34
2024
25718
0.910
 Why?
Pregnanolone
2
2023
6
0.890
 Why?
Female
30
2024
26981
0.890
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.840
 Why?
Quality Improvement
2
2022
206
0.810
 Why?
Treatment Outcome
10
2024
5230
0.810
 Why?
Aphasia
1
2022
32
0.800
 Why?
Nervous System Diseases
2
2021
88
0.780
 Why?
Chromosome Deletion
3
2019
140
0.770
 Why?
Abnormalities, Multiple
3
2023
167
0.770
 Why?
Emergencies
1
2021
80
0.740
 Why?
Pharmaceutical Preparations
1
2021
76
0.730
 Why?
Angelman Syndrome
1
2020
1
0.720
 Why?
Transition to Adult Care
1
2020
17
0.720
 Why?
Immunoglobulins, Intravenous
1
2021
55
0.700
 Why?
Bone Diseases, Developmental
2
2023
14
0.700
 Why?
Tooth Abnormalities
2
2023
12
0.700
 Why?
Oligonucleotides, Antisense
1
2020
28
0.690
 Why?
Phenobarbital
1
2020
17
0.680
 Why?
Behavioral Symptoms
1
2019
3
0.680
 Why?
Flunarizine
1
2019
1
0.680
 Why?
Immunologic Factors
1
2021
111
0.680
 Why?
Excitatory Amino Acid Antagonists
1
2020
50
0.670
 Why?
Ocular Physiological Phenomena
1
2019
4
0.670
 Why?
Tetrasomy
1
2019
2
0.660
 Why?
Agenesis of Corpus Callosum
2
2018
11
0.660
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.660
 Why?
Sneddon Syndrome
1
2019
3
0.660
 Why?
Livedo Reticularis
1
2019
6
0.660
 Why?
Oral Ulcer
1
2019
3
0.650
 Why?
Calcium Channel Blockers
1
2019
64
0.650
 Why?
Behcet Syndrome
1
2019
7
0.650
 Why?
Transposases
1
2019
10
0.650
 Why?
Andersen Syndrome
1
2019
1
0.640
 Why?
Spinal Cord Diseases
1
2019
37
0.640
 Why?
Hydrocephalus
1
2019
43
0.640
 Why?
Receptors, GABA-B
1
2019
11
0.640
 Why?
Vitiligo
1
2019
8
0.640
 Why?
Genetic Therapy
1
2020
118
0.640
 Why?
Nephrotic Syndrome
2
2017
18
0.640
 Why?
Leukoencephalopathies
1
2019
14
0.640
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.630
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.630
 Why?
Migraine Disorders
2
2020
44
0.630
 Why?
Edema
1
2019
68
0.630
 Why?
Electron Transport Complex IV
1
2018
28
0.620
 Why?
Cerebral Infarction
1
2018
35
0.620
 Why?
Cannabinoid Receptor Agonists
1
2019
49
0.620
 Why?
Muscle Weakness
1
2019
45
0.620
 Why?
Physicians
1
2022
229
0.620
 Why?
Optic Atrophy
1
2018
16
0.620
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.620
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.620
 Why?
Shab Potassium Channels
1
2018
2
0.620
 Why?
Photic Stimulation
1
2018
59
0.620
 Why?
Alopecia
1
2019
37
0.610
 Why?
Brain Edema
1
2018
41
0.610
 Why?
Parents
1
2021
320
0.610
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
27
0.600
 Why?
Thrombocytopenia
1
2019
84
0.600
 Why?
Autoimmune Diseases
1
2019
80
0.600
 Why?
Myoclonus
1
2018
9
0.600
 Why?
Artifacts
1
2018
54
0.590
 Why?
Biomedical Research
1
2021
242
0.590
 Why?
Mitochondrial Diseases
1
2018
42
0.590
 Why?
Neurodegenerative Diseases
1
2018
75
0.580
 Why?
Practice Guidelines as Topic
1
2020
460
0.580
 Why?
Hearing Loss, Sensorineural
1
2018
76
0.570
 Why?
Osteochondrodysplasias
1
2017
13
0.560
 Why?
Health Knowledge, Attitudes, Practice
1
2021
490
0.560
 Why?
Immunologic Deficiency Syndromes
1
2017
19
0.560
 Why?
Adolescent
13
2024
6475
0.560
 Why?
Models, Biological
1
2020
723
0.560
 Why?
Phenotype
2
2021
736
0.560
 Why?
Arteriosclerosis
1
2017
54
0.550
 Why?
Carotid Artery Diseases
1
2017
32
0.550
 Why?
Infant, Newborn
6
2024
2780
0.550
 Why?
Drug Discovery
1
2017
83
0.550
 Why?
Child Development
1
2018
193
0.540
 Why?
Prenatal Exposure Delayed Effects
1
2018
186
0.540
 Why?
Cafe-au-Lait Spots
1
2016
2
0.530
 Why?
Erythema Infectiosum
1
2015
3
0.520
 Why?
Migraine with Aura
1
2015
4
0.520
 Why?
Williams Syndrome
1
2016
26
0.520
 Why?
Skin
1
2019
417
0.520
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.520
 Why?
Corpus Callosum
2
2023
29
0.520
 Why?
Syndrome
6
2024
239
0.520
 Why?
Sinus Pericranii
1
2015
1
0.510
 Why?
Parvovirus B19, Human
1
2015
17
0.510
 Why?
Toes
1
2015
14
0.510
 Why?
Pulmonary Embolism
1
2017
98
0.510
 Why?
SOS1 Protein
1
2015
2
0.510
 Why?
Electrodiagnosis
1
2015
12
0.510
 Why?
Crying
1
2015
4
0.510
 Why?
Moyamoya Disease
1
2015
7
0.510
 Why?
Hyperventilation
1
2015
8
0.510
 Why?
Iatrogenic Disease
1
2015
24
0.500
 Why?
Tuberculoma
1
2015
2
0.500
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.500
 Why?
Noonan Syndrome
1
2015
12
0.500
 Why?
Neurologic Examination
1
2015
76
0.500
 Why?
Encephalitis
1
2016
40
0.500
 Why?
Communication
3
2022
246
0.490
 Why?
Mutism
1
2015
3
0.490
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.490
 Why?
Ocular Motility Disorders
1
2015
17
0.490
 Why?
TOR Serine-Threonine Kinases
1
2015
77
0.490
 Why?
Repressor Proteins
2
2023
149
0.490
 Why?
Diagnosis, Differential
7
2020
1042
0.480
 Why?
Trisomy
1
2014
31
0.480
 Why?
Influenza, Human
1
2015
83
0.470
 Why?
Neurology
1
2015
36
0.470
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.470
 Why?
Energy Drinks
1
2014
6
0.470
 Why?
Vasoconstriction
1
2014
55
0.460
 Why?
Benzodiazepines
1
2014
70
0.460
 Why?
Osteomyelitis
1
2015
125
0.450
 Why?
Membrane Proteins
1
2016
348
0.450
 Why?
Sleep
1
2014
180
0.430
 Why?
Enzyme Inhibitors
1
2015
378
0.430
 Why?
Magnetic Resonance Angiography
3
2019
71
0.410
 Why?
Immunosuppressive Agents
3
2019
223
0.400
 Why?
Consensus
2
2025
159
0.390
 Why?
Pediatrics
1
2015
280
0.390
 Why?
Quality of Life
3
2022
844
0.370
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
127
0.350
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
125
0.350
 Why?
Clinical Trials as Topic
2
2024
465
0.350
 Why?
Caregivers
2
2021
213
0.330
 Why?
Recurrence
3
2019
664
0.320
 Why?
Echinocandins
1
2008
64
0.310
 Why?
Mycoses
1
2008
158
0.290
 Why?
Gastroesophageal Reflux
2
2019
50
0.280
 Why?
Antifungal Agents
1
2008
342
0.260
 Why?
Administration, Topical
2
2015
57
0.250
 Why?
Retrospective Studies
6
2023
6223
0.250
 Why?
Seizures, Febrile
1
2024
2
0.240
 Why?
Meta-Analysis as Topic
1
2024
38
0.240
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.230
 Why?
Adult
5
2024
13568
0.230
 Why?
Databases, Factual
2
2024
667
0.230
 Why?
Psychosurgery
1
2023
5
0.230
 Why?
Laser Therapy
1
2023
84
0.210
 Why?
Speech Disorders
1
2022
15
0.210
 Why?
Ethosuximide
1
2022
5
0.210
 Why?
Clonazepam
1
2022
6
0.210
 Why?
Electrodes, Implanted
1
2022
29
0.200
 Why?
Cluster Analysis
1
2023
231
0.200
 Why?
Stereotaxic Techniques
1
2022
37
0.200
 Why?
Death, Sudden
1
2022
10
0.200
 Why?
GTPase-Activating Proteins
1
2022
23
0.200
 Why?
Palliative Care
1
2024
188
0.200
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
 Why?
Freedom
1
2021
3
0.190
 Why?
Diazepam
1
2021
17
0.190
 Why?
Folic Acid
1
2022
139
0.190
 Why?
Drug Interactions
1
2022
208
0.190
 Why?
Fibroma
1
2021
39
0.190
 Why?
Risk Factors
2
2020
3692
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
31
0.180
 Why?
Personal Satisfaction
1
2021
77
0.180
 Why?
Soft Tissue Neoplasms
1
2021
56
0.180
 Why?
Brain Diseases
1
2021
80
0.180
 Why?
Dihydroergotamine
1
2020
4
0.180
 Why?
Perception
1
2021
116
0.180
 Why?
Facies
2
2023
35
0.170
 Why?
Transcription Factors
2
2023
566
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
23
0.170
 Why?
Clinical Protocols
1
2020
109
0.170
 Why?
Treatment Failure
1
2020
115
0.170
 Why?
Ubiquitin-Protein Ligases
1
2020
93
0.170
 Why?
Anesthetics
1
2020
36
0.170
 Why?
Leukomalacia, Periventricular
1
2019
12
0.170
 Why?
Muscle Hypotonia
1
2019
22
0.170
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.170
 Why?
Matrix Attachment Region Binding Proteins
1
2020
35
0.160
 Why?
Learning
1
2021
158
0.160
 Why?
Patient-Centered Care
1
2021
129
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Qualitative Research
1
2021
338
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
115
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
26
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
44
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
 Why?
Disease Management
1
2020
175
0.160
 Why?
Ventricular Premature Complexes
1
2019
7
0.160
 Why?
Microcephaly
1
2019
41
0.160
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.160
 Why?
Facial Nerve Diseases
1
2018
6
0.160
 Why?
Referral and Consultation
1
2021
284
0.160
 Why?
Syncope
1
2019
29
0.160
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.160
 Why?
Cerebral Veins
1
2018
15
0.150
 Why?
Facial Paralysis
1
2018
23
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.150
 Why?
Deglutition Disorders
1
2019
76
0.150
 Why?
Health Personnel
1
2021
252
0.150
 Why?
Acute Disease
1
2019
370
0.150
 Why?
Fatal Outcome
1
2019
195
0.150
 Why?
Video Recording
1
2018
79
0.150
 Why?
Frameshift Mutation
1
2018
17
0.150
 Why?
Fibrinolytic Agents
1
2019
126
0.150
 Why?
Combined Modality Therapy
1
2020
641
0.150
 Why?
Anti-Inflammatory Agents
1
2019
162
0.150
 Why?
Fear
1
2018
84
0.150
 Why?
India
1
2017
52
0.150
 Why?
Platelet Aggregation Inhibitors
1
2019
174
0.140
 Why?
Cerebellum
1
2018
132
0.140
 Why?
History, 21st Century
1
2017
56
0.140
 Why?
History, 20th Century
1
2017
95
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
73
0.140
 Why?
Pandemics
1
2021
564
0.140
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
85
0.140
 Why?
Anti-Infective Agents
1
2017
95
0.140
 Why?
Animals
3
2022
13173
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
 Why?
Hormones
1
2016
57
0.130
 Why?
Influenza B virus
1
2015
6
0.130
 Why?
Delayed Diagnosis
1
2016
24
0.130
 Why?
Chromosomes, Human, Pair 3
1
2015
19
0.130
 Why?
Arkansas
1
2021
1991
0.130
 Why?
North America
1
2015
66
0.130
 Why?
Cerebral Angiography
1
2015
97
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
77
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
19
0.120
 Why?
Complementary Therapies
1
2015
25
0.120
 Why?
Brain Waves
1
2014
18
0.120
 Why?
Drug Resistance
1
2015
64
0.120
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
456
0.110
 Why?
Headache
1
2014
76
0.110
 Why?
Glutamine
1
2015
173
0.110
 Why?
Mutation, Missense
1
2014
104
0.110
 Why?
Vomiting
1
2014
73
0.110
 Why?
Arginine
1
2015
185
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.110
 Why?
Analgesics
1
2014
104
0.110
 Why?
Diagnostic Errors
1
2013
66
0.100
 Why?
Evidence-Based Medicine
1
2013
249
0.100
 Why?
Inflammation
1
2016
608
0.090
 Why?
Pregnancy
1
2018
2610
0.090
 Why?
Signal Transduction
1
2017
1625
0.090
 Why?
Antineoplastic Agents
1
2017
1178
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
41
0.080
 Why?
Lipopeptides
1
2008
63
0.080
 Why?
Amyloidosis
1
2009
78
0.080
 Why?
Inflammatory Bowel Diseases
1
2009
50
0.080
 Why?
Tuberculosis
1
2009
149
0.070
 Why?
Candidiasis
1
2008
114
0.070
 Why?
Aspergillosis
1
2008
125
0.070
 Why?
Kidney Diseases
1
2009
213
0.070
 Why?
Prospective Studies
2
2023
2414
0.070
 Why?
Spasm
1
2024
9
0.060
 Why?
Observer Variation
1
2024
139
0.060
 Why?
Feedback
1
2024
52
0.060
 Why?
Probability
1
2023
165
0.050
 Why?
Neuroimaging
1
2023
86
0.050
 Why?
Neurosurgical Procedures
1
2024
123
0.050
 Why?
Potassium Channels
1
2021
33
0.050
 Why?
Registries
1
2024
539
0.050
 Why?
Reproducibility of Results
1
2024
1201
0.040
 Why?
Administration, Intravenous
1
2020
70
0.040
 Why?
Sleep Stages
1
2020
42
0.040
 Why?
Age of Onset
1
2020
108
0.040
 Why?
Cognition
1
2022
314
0.040
 Why?
Immunohistochemistry
1
2021
975
0.040
 Why?
Software
1
2013
274
0.020
 Why?
Internet
1
2013
261
0.020
 Why?
Young Adult
1
2020
4064
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
106
0.020
 Why?
Colonoscopy
1
2009
98
0.020
 Why?
Prognosis
1
2009
1979
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (329) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department